Status:
COMPLETED
Study of Low Dose CT in Sarcoma Patients
Lead Sponsor:
University Health Network, Toronto
Conditions:
Soft Tissue Sarcoma
Eligibility:
All Genders
16+ years
Phase:
PHASE1
Brief Summary
The primary outcome of this study is the detection of lung metastases comparing Low dose CT (LDCT) and Minimum dose CT (MnDCT) with CXR. Hypothesis 1. LDCT and MnDCT have similar sensitivity for the...
Detailed Description
A 3-year prospective phase II non-randomized study commenced May 2003 enrolling 60 high-risk patients with Intermediate and High Grade STS. Each patient is kept under radiological surveillance for 3 y...
Eligibility Criteria
Inclusion
- High Grade Soft tissue sarcoma
Exclusion
- None
Key Trial Info
Start Date :
August 1 2003
Trial Type :
INTERVENTIONAL
End Date :
January 1 2006
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT00188422
Start Date
August 1 2003
End Date
January 1 2006
Last Update
April 23 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mount Sinai Hospital
Toronto, Ontario, Canada